Presence of aldose reductase inhibitors in tea leaves

Japanese Journal of Pharmacology

Volumn 85, Issue 3, 2001, Pages 322-326

  Sakai, I ^a   Izumi, S I ^a   Murano, T ^a   Okuwaki, S ^a   Makino, T ^a   Suzuki, T ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

Aldose reductase; Diabetes; Enzyme inhibitor; Human placenta; Tea leaf

Indexed keywords

ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; GLUCOSE; ISOQUERCITRIN; OXIDOREDUCTASE; SORBITOL; WATER;

ANIMAL TISSUE; ARTICLE; ASSAY; DIABETES MELLITUS; DIABETOGENESIS; DISEASE COURSE; DRUG ACTIVITY; DRUG ISOLATION; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INHIBITION KINETICS; NONHUMAN; PATHOGENESIS; PLACENTA; PLANT LEAF; RAT; REVERSED PHASE LIQUID CHROMATOGRAPHY; SCIATIC NERVE; TEA; TISSUE PREPARATION;

EID: 0035068766     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.85.322     Document Type: Article

References (25)

1. Pathogenesis of diabetic neuropathy
2. Lessons from the diabetes control and complications trial
3. Formation of polyols by the lens of the rat with "sugar" cataract
4. Treatment of diabetic retinopathy: A view for the internist
5. Modification of the glyoxalase system in streptozotocin-indued diabetic rats. Effect of the aldose reductase inhibitor Statil
6. The efficacy of aldose reductase inhibitors on polyol accumulation in human lens and retinal pigment epithelium in tissue culture
7. Aldose reductase inhibitors and diabetic complications
8. Characterization of a novel aldose reductase inhibitor, TAT, and its effects on streptozotocin-induced diabetic neuropathy in rats
9. Novel spirosuccinimide aldose reductase inhibitors derived from isoquinoline-1,3-diones: 2-[(4-bromo-2-fluorophenyl) methyl]-6-fluorospiro [isoquiniline4 (1H), 3′pyrrolidine]-1,2′,3,5′ (2H)-tetrone and congeners
10. Recent clinical experience with ARIs
11. Effects of ARIs on the progression of nerve fiber damage in diabetic neuropathy
12. The effect of aldose reductase inhibitor, ponalrestat, on the progression of diabetic retinopathy
13. Short term effect of an aldose reductase inhibitor on urinary albumin excretion rate (UAER) and glomerular filtration rate (GFR) in type 1 diabetic patients with incipient nephropathy
14. Effect of aldose reductase inhibitor (tolrestat) on urinary albumin excretion rate and glomerular filtration rate in IDDM subjects with nephropathy
15. Long-term effects of tolrestat on symptomatic diabetic sensory polyneuropathy
16. Clinical trials of 5-[(1E,2E)-2-methyl-3-phenylpropenylidene]-4-oxo-2-thioxo-3-thiazolizineacetic acid (ONO-2235)
17. Isolation and properties of lens aldose reductase
18. D-Sorbitol
19. Red cell sorbitol, an indicator of diabetic control
20. Effects of a new aldose reductase inhibitor on various tissues in vitro
21. (2,6-Dimethylphenylsulphonyl) nitromethane: A new structural type of aldose reductase inhibitor which follows kinetics and uses an allosteric binding site
22. Properties of novel aldose reductase inhibitors, M16209 and M16287, in comparison with known inhibitors, ONO-2235 and sorbinil
23. An unlikely sugar substrate site in the 1.65 A structure of human aldose reductase holoenzyme implicated in diabetic complication
24. Protective effects of some flavonoids on the renal cellular membrane
25. Angiotensin converting enzyme (ACE) inhibitors from Jasminum azoricum and Jasminum grandiflorum